SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-016581
Filing Date
2019-03-21
Accepted
2019-03-21 16:16:28
Documents
7
Period of Report
2019-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-6993_18k.htm 8-K 33702
2 EX-5.1 a19-6993_1ex5d1.htm EX-5.1 12868
3 EX-10.1 a19-6993_1ex10d1.htm EX-10.1 198283
4 EX-10.2 a19-6993_1ex10d2.htm EX-10.2 110284
5 EX-99.1 a19-6993_1ex99d1.htm EX-99.1 7736
6 GRAPHIC g69931mmi001.jpg GRAPHIC 2952
7 GRAPHIC g69931kii001.jpg GRAPHIC 7498
  Complete submission text file 0001104659-19-016581.txt   378783
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 19697224
SIC: 2834 Pharmaceutical Preparations